An interaction between SARS-CoV-2 nucleoprotein with α-synuclein may accelerate the formation of amyloid fibrils and provide the molecular basis for the observed correlation between SARS-CoV-2 infection and Parkinsonism, according to study results published in the journal ACS Chemical Neuroscience.